Sort   by:  
 Page size 
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
UnknownEfficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Not available
S-EPMC8693692 | biostudies-literature
UnknownGWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Not available
S-EPMC3693183 | biostudies-literature
UnknownAssociation Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Not available
S-EPMC8524310 | biostudies-literature
UnknownVariation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Not available
S-EPMC4082406 | biostudies-literature
UnknownA genome-wide association meta-analysis of all-cause and vascular dementia.
Not available
S-EPMC11497727 | biostudies-literature
UnknownPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636 | biostudies-literature
UnknownIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Not available
S-EPMC3709460 | biostudies-literature
UnknownRare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Not available
S-EPMC5669039 | biostudies-literature
UnknownIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Not available
S-EPMC5612337 | biostudies-literature
Sort   by:  
 Page size